Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

The objective of this study was to evaluate the efficacy and safety of divalproex sodium extended release (divalproex ER) vs placebo in combination with olanzapine or risperidone for the treatment of acute exacerbations of schizophrenia. In this 12-week, randomized, double-blind, parallel-group, mul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2009-04, Vol.34 (5), p.1330-1338
Hauptverfasser:	Casey, Daniel E, Daniel, David G, Tamminga, Carol, Kane, John M, Tran-Johnson, Tram, Wozniak, Patricia, Abi-Saab, Walid, Baker, Jeff, Redden, Laura, Greco, Nicholas, Saltarelli, Mario
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Adult and adolescent clinical studies Aged Analysis of Variance Antipsychotic Agents - therapeutic use Antipsychotics Behavioral Sciences Benzodiazepines - therapeutic use Biological and medical sciences Biological Psychology Dopamine Double-Blind Method Drug Therapy, Combination Female Humans Male Medical sciences Medicine Medicine & Public Health Middle Aged Neuropharmacology Neurosciences original-article Patients Pharmacology. Drug treatments Pharmacotherapy Psychiatric Status Rating Scales Psychiatry Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychoses Psychosis Psychotropic drugs Risperidone - therapeutic use Schizophrenia Schizophrenia - drug therapy Sodium Treatment Outcome Valproic Acid - blood Valproic Acid - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!